← All Topics / ade

FDA ADE reports for Lufenuron (insect development inhibitor (flea)) — total reports, species & reaction breakdown

ade_lufenuron_adverse_events

ade 208 tok en 2026-07-21

Lufenuron — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-21. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Lufenuron is a insect development inhibitor (flea).

Total reports

Lufenuron: 39711

Reports by species (top entries)

  • Dog 36594
  • Cat 1148
  • Human 108
  • Ferret 3
  • Other 3
  • Goat 2

Top reported reactions (VEDDRA terms, top entries)

  • INEFFECTIVE, HEARTWORM LARVAE 5705
  • Vomiting 5631
  • Lack of efficacy (endoparasite) - hookworm 4233
  • Lack of efficacy (endoparasite) - heartworm 3523
  • Diarrhoea 3146
  • INEFFECTIVE, ASCARIDS NOS 2000
  • Lethargy (see also Central nervous system depression in 'Neurological') 1917
  • INEFFECTIVE, HOOKS 1869
  • Lack of efficacy - NOS 1371
  • Depression 1343

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-21.json (openFDA animalandveterinary/event.json, pulled 2026-07-21).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-21